Stereotaxis, Inc. designs, manufactures and markets robotic magnetic navigation systems for use in a hospital's interventional surgical suite to enhance the treatment of arrhythmias and coronary artery disease. The company is headquartered in St. Louis, Missouri and currently employs 131 full-time employees. The company went IPO on 2004-08-12. Its proprietary robotic technology, Robotic Magnetic Navigation (RMN), fundamentally transforms endovascular interventions using precise computer-controlled magnetic fields to directly control the tip of flexible interventional catheters or devices. The Company’s primary products include the Genesis RMN System, the Odyssey Solution, and other related devices. Through its strategic relationships with fluoroscopy system manufacturers, providers of catheters and electrophysiology mapping systems, and other parties, the Company offers its customers x-ray systems and other accessory devices. The Genesis RMN System is designed to enable physicians to complete more complex interventional procedures by providing image-guided delivery of catheters through the blood vessels and chambers of the heart to treatment sites.
Mr. David Fischel is the Chairman of the Board of Stereotaxis Inc, joining the firm since 2016.
What is the price performance of STXS stock?
The current price of STXS is $1.68, it has decreased 0% in the last trading day.
What are the primary business themes or industries for Stereotaxis Inc?
Stereotaxis Inc belongs to Health Care industry and the sector is Health Care
What is Stereotaxis Inc market cap?
Stereotaxis Inc's current market cap is $164.2M
Is Stereotaxis Inc a buy, sell, or hold?
According to wall street analysts, 6 analysts have made analyst ratings for Stereotaxis Inc, including 2 strong buy, 7 buy, 1 hold, 0 sell, and 2 strong sell